General Information of the Protein
| Protein ID |
PT03373
|
||||
|---|---|---|---|---|---|
| Protein Name |
Gamma-aminobutyric acid receptor subunit alpha-3
|
||||
| Secondarily Protein Name |
GABA(A) receptor subunit alpha-3
|
||||
| Gene Name |
GABRA3
|
||||
| Sequence |
MIITQTSHCYMTSLGILFLINILPGTTGQGESRRQEPGDFVKQDIGGLSPKHAPDIPDDSTDNITIFTRILDRLLDGYDNRLRPGLGDAVTEVKTDIYVTSFGPVSDTDMEYTIDVFFRQTWHDERLKFDGPMKILPLNNLLASKIWTPDTFFHNGKKSVAHNMTTPNKLLRLVDNGTLLYTMRLTIHAECPMHLEDFPMDVHACPLKFGSYAYTTAEVVYSWTLGKNKSVEVAQDGSRLNQYDLLGHVVGTEIIRSSTGEYVVMTTHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLNRESVPARTVFGVTTVLTMTTLSISARNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVNYFTKRSWAWEGKKVPEALEMKKKTPAAPAKKTSTTFNIVGTTYPINLAKDTEFSTISKGAAPSASSTPTIIASPKATYVQDSPTETKTYNSVSKVDKISRIIFPVLFAIFNLVYWATYVNRESAIKGMIRKQ
Show/Hide
|
||||
| Organism |
Homo sapiens, Human
|
||||
| Protein Classification |
Ion channel
>
Ligand-gated ion channel
>
GABA-A receptor
|
||||
| Function |
GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.
Show/Hide
|
||||
| Uniprot ID |
Show/Hide
|
||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Subcellular Location |
Postsynaptic cell membrane
Cell membrane
|
||||
Map of Molecular Bioactivity Related to the Protein
|
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Clinical Information about the Protein
Target 1 ( GABA(A) receptor alpha-3 (GABRA3) )
| Target Type | Successful Target | ||||
|---|---|---|---|---|---|
| Disease | 5 Target-related Diseases | 5 | |||
| 1 | Benzodiazepine overdose [ICD-11: PC91] | ||||
| 2 | Inflammatory bowel disease [ICD-11: DD72] | ||||
| 3 | Anxiety disorder [ICD-11: 6B00-6B0Z] | ||||
| 4 | Schizophrenia [ICD-11: 6A20] | ||||
| 5 | Inflammation [ICD-11: 1A00-CA43.1] | ||||
| Approved Drug(s) | 1 Approved Drug | 1 | |||
| 1 | Flumazenil | Approved | |||
| Clinical Trial Drug(s) | 2 Clinical Trial Drugs | 2 | |||
| 1 | GSK683699 | Phase 2 | |||
| 2 | NS-2710 | Phase 2 | |||
| Discontinued Drug(s) | 1 Discontinued Drug | 1 | |||
| 1 | AZD6280 | Discontinued in Phase 1 | |||
| Investigative Drug(s) | 1 Investigative Drug | 1 | |||
| 1 | [3H]CGS8216 | Investigative | |||
Similar Protein(s) and Bioactivity Statistics
50% Identity
| Protein ID | Protein Name | Protein Organism | |
| PT02002 | Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens, Human | |
|---|---|---|---|